Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.700
-0.010 (-0.37%)
Aug 15, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 524.73 million as of August 15, 2025. Its market cap has increased by 6.82% in one year.
Market Cap
524.73M
Enterprise Value
818.88M
Revenue
728.27M
Ranking
n/a
PE Ratio
17.58
Stock Price
2.70
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 524.73M, a decrease of -23.98%. That is a compound annual growth rate of -6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 524.73M | -23.34% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.52B |
| Pro Medicus | 32.98B |
| Cochlear | 20.49B |
| Sonic Healthcare | 13.81B |
| Ramsay Health Care | 8.92B |
| Telix Pharmaceuticals | 5.80B |
| Ansell | 4.57B |
| Mesoblast | 3.11B |